Cargando…
Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort
BACKGROUND: Due to the high prevalence of resistance to NNRTI-based ART since 2018, consolidated recommendations from the WHO have indicated dolutegravir as the preferred drug of choice for HIV treatment globally. There is a paucity of resistance outcome data from HIV-1 non-B subtypes circulating ac...
Autores principales: | Abdullahi, Adam, Kida, Ibrahim Musa, Maina, Umar Abdullahi, Ibrahim, Amina Husaini, Mshelia, James, Wisso, Haruna, Adamu, Abdullahi, Onyemata, James Ezenwa, Edun, Martin, Yusuph, Haruna, Aliyu, Sani H, Charurat, Man, Abimiku, Alash’le, Abeler-Dorner, Lucie, Fraser, Christophe, Bonsall, David, Kemp, Steven A, Gupta, Ravindra K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393879/ https://www.ncbi.nlm.nih.gov/pubmed/37367727 http://dx.doi.org/10.1093/jac/dkad195 |
Ejemplares similares
-
Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV
por: Dow, Dorothy E., et al.
Publicado: (2014) -
Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa
por: Aliyu, Gambo, et al.
Publicado: (2018) -
Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus
por: Dakum, Patrick, et al.
Publicado: (2019) -
Performance of SARS COV-2 IgG Anti-N as an Independent Marker of Exposure to SARS COV-2 in an Unvaccinated West African Population
por: Abdullahi, Adam, et al.
Publicado: (2023) -
2492. Differences between Individuals Currently Taking Integrase Inhibitor (INSTI)-based Therapy and Those Not Taking INSTIs in the Era of INSTIs as Recommended First-line Therapy
por: Monroe, Anne K, et al.
Publicado: (2019)